Home > Gastroenterology > DDW 2022 > Other Highlighted Research > Faecal microbiota transplantation: a safe procedure to treat recurrent Clostridium difficile infections

Faecal microbiota transplantation: a safe procedure to treat recurrent Clostridium difficile infections

Presented By
Dr Eliot A. Rapoport, University of Illinois College of Medicine, IL, USA
Presented by
Eliot Rapoport University of Illinois Urbana-Champaign
Conference
DDW 2022
Doi
https://doi.org/10.55788/a579f0c3
A meta-analysis of patients receiving treatment for Clostridium difficile infection showed that faecal microbiota transplantation is generally a safe procedure, with the most significant adverse events being unrelated to the intervention. The majority of adverse events observed were minor and were commonly abdominal pain, constipation, nausea, and vomiting.  Despite the efficacy of faecal microbiota transplantation (FMT), the procedure is still highly underutilised, probably due to concerns over its safety. To shed light on this issue, Dr Eliot A. Rapoport (University of Illinois College of Medicine, IL, USA) and colleagues performed a meta-analysis including 61 unique original research studies on FMT for Clostridium difficile infections (CDI) [1]. The literature search was conducted using MEDLINE through PubMed, Ovid, Cochrane Library, and EMBASE from 2015 to 2021. Published articles written in En...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on